ribavirin has been researched along with Hantavirus Pulmonary Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brocato, RL; Hooper, JW | 1 |
| Camp, JV; Hooper, JW; Jonsson, CB; Ogg, M | 1 |
| Macneil, A; Nichol, ST; Spiropoulou, CF | 1 |
| Baum, K; Fernandez, H; Goade, D; Hansbarger, CO; Hjelle, B; Koster, FT; Levy, H; Lindemulder, A; Mertz, GJ; Miedzinski, L; Pavia, AT; Riser, L; Wang, W; Whitley, RJ | 1 |
| Johann-Liang, R; Marcus, KA; Powers, JH | 1 |
| Hjelle, B; Hutt, J; Medina, RA; Mirowsky-Garcia, K | 1 |
| Hooper, J; Jonsson, CB; Mertz, G | 1 |
| Levy, DL | 1 |
| Warner, GS | 1 |
| Stelzel, W | 1 |
| Bryan, RT; Hjelle, BL; Mertz, GJ | 1 |
| Seijó, AC | 1 |
| Le Guenno, B | 1 |
| Baum, KF; Behrman, RE; Bell, LJ; Chapman, LE; Christenson, JC; Holman, RC; Jolson, HM; Khan, AS; Koster, FT; Ksiazek, TG; Mertz, GJ; Pavia, AT; Peters, CJ; Rollin, PE; Rubin, PJ; Sadek, RF; Simpson, GL | 1 |
7 review(s) available for ribavirin and Hantavirus Pulmonary Syndrome
| Article | Year |
|---|---|
Progress on the Prevention and Treatment of Hantavirus Disease.
Topics: Adrenal Cortex Hormones; Amides; Animals; Antiviral Agents; Clinical Trials as Topic; Hantavirus Infections; Hantavirus Pulmonary Syndrome; Hemorrhagic Fever with Renal Syndrome; Humans; Immunotherapy; Lactoferrin; Models, Animal; Nucleosides; Orthohantavirus; Piperidines; Pyrazines; Quinazolines; Recombinant Proteins; Ribavirin; Triazoles; Vaccines, Synthetic; Viral Vaccines | 2019 |
Hantavirus pulmonary syndrome.
Topics: Animals; Antiviral Agents; Cricetinae; Europe; Genome, Viral; Hantaan virus; Hantavirus Pulmonary Syndrome; Hemorrhagic Fever with Renal Syndrome; Humans; Lung; North America; Orthohantavirus; Phylogeography; Respiratory Insufficiency; Ribavirin; Shock, Cardiogenic; Sin Nombre virus; South America | 2011 |
Treatment of hantavirus pulmonary syndrome.
Topics: Animals; Antiviral Agents; Cricetinae; Disease Models, Animal; Hantavirus Pulmonary Syndrome; Humans; Immunotherapy; Mice; Orthohantavirus; Radiography; Rats; Ribavirin | 2008 |
Hantavirus pulmonary syndrome. Outbreak of a new disease caused by a new virus.
Topics: Adult; Animals; Disease Outbreaks; Female; Hantavirus Pulmonary Syndrome; Humans; Indians, North American; Male; Mice; Middle Aged; Ribavirin; Southwestern United States; United States | 1995 |
Hantavirus illness in humans: review and update.
Topics: Antiviral Agents; Hantavirus Infections; Hantavirus Pulmonary Syndrome; Hemorrhagic Fever with Renal Syndrome; Humans; Infection Control; Ribavirin | 1996 |
Hantavirus infection.
Topics: Antibodies, Viral; Antiviral Agents; Extracorporeal Membrane Oxygenation; Hantavirus Infections; Hantavirus Pulmonary Syndrome; Hemorrhagic Fever with Renal Syndrome; Humans; North America; Ribavirin; South America | 1997 |
[Hantavirus and pulmonary pathology].
Topics: Adult; Antibodies, Viral; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Female; Hantavirus Pulmonary Syndrome; Hemorrhagic Fever with Renal Syndrome; Humans; Immunoglobulin M; Male; Orthohantavirus; Ribavirin | 1998 |
2 trial(s) available for ribavirin and Hantavirus Pulmonary Syndrome
| Article | Year |
|---|---|
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.
Topics: Adult; Antiviral Agents; Double-Blind Method; Female; Hantavirus Pulmonary Syndrome; Humans; Injections, Intravenous; Male; Middle Aged; North America; Placebos; Ribavirin | 2004 |
Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.
Topics: Adult; Female; Hantavirus Pulmonary Syndrome; Humans; Infusions, Intravenous; Male; Ribavirin; Selection Bias; United States | 1999 |
5 other study(ies) available for ribavirin and Hantavirus Pulmonary Syndrome
| Article | Year |
|---|---|
Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus.
Topics: Animals; Antiviral Agents; Cricetinae; Disease Models, Animal; Female; Hantavirus Pulmonary Syndrome; Humans; Mesocricetus; Nasal Cavity; Orthohantavirus; Ribavirin | 2013 |
Ribavirin trials and hantavirus--what we should not conclude.
Topics: Antiviral Agents; Controlled Clinical Trials as Topic; Hantavirus Pulmonary Syndrome; Humans; Reproducibility of Results; Ribavirin; Sample Size; Severe Acute Respiratory Syndrome | 2005 |
Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model.
Topics: Abciximab; Animals; Antibodies; Antibodies, Monoclonal; Antiviral Agents; Disease Models, Animal; Hantavirus Pulmonary Syndrome; Humans; Immune Sera; Immunoglobulin Fab Fragments; Integrin beta3; Peromyscus; Rabbits; Ribavirin; Sin Nombre virus; Treatment Outcome | 2007 |
Hantavirus pulmonary syndrome: epidemiology, prevention, and case presentation of a new viral strain.
Topics: Adult; Fatal Outcome; Hantavirus Pulmonary Syndrome; Humans; Incidence; Male; Orthohantavirus; Prevalence; Ribavirin | 1996 |
[Pathogenesis, physiopathology, clinical manifestations and treatment of Hantavirus pulmonary syndrome].
Topics: Acetaminophen; Antiviral Agents; Diagnosis, Differential; Hantavirus Pulmonary Syndrome; Humans; Ribavirin | 1998 |